Revance Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Revance Therapeutics

08/08/2024 22:52

* Revance Therapeutics Inc  RVNC.OQ  reported a quarterly
adjusted
loss of 36 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -80 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 53 cents per
share. Wall Street expected results to range from -86 cents
to -39 cents per share.
    * Revenue rose 12.5% to $65.39 million from a year ago;
analysts
expected $66.06 million. 
    * Revance Therapeutics Inc's reported EPS for the quarter
was a
loss of 36 cents​.
    * The company reported a quarterly loss of $37.47 million.
    * Revance Therapeutics Inc shares had risen by 9.7% this
quarter and lost 67.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Revance
Therapeutics Inc is $11.00 
This summary was machine generated from LSEG data August 8 at
09:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.53          -0.36          Beat
 Mar. 31 2024      -0.75          -0.58          Beat
 Dec. 31 2023      -0.72          -0.62          Beat
 Sep. 30 2023      -0.85          -1.63          Missed